Related Experiment Video

Updated: Aug 9, 2026

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses
06:13

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Published on: November 24, 2014

Reovirus as an oncolytic agent against experimental human malignant gliomas

M E Wilcox1, W Yang, D Senger

  • 1Departments of Oncology and Clinical Neurosciences, University of Calgary, and Tom Baker Cancer Centre, Alberta, Canada.

Journal of the National Cancer Institute
|June 21, 2001
PubMed
Abstract

Insights

Reovirus effectively targets and destroys malignant glioma cells in laboratory and animal studies. This oncolytic virus shows potent anti-glioma activity, suggesting its potential as a novel cancer therapy.

Area of Science:

  • Oncology
  • Virology
  • Cancer Research

Background:

  • Reovirus is a naturally occurring oncolytic virus.
  • It replicates in tumor cells by exploiting activated Ras-signaling pathways.
  • Ras pathways are frequently activated in malignant gliomas.

Purpose of the Study:

  • To evaluate the efficacy of reovirus as an experimental treatment for malignant gliomas.
  • To determine reovirus's oncolytic potential against glioma cell lines and patient-derived tumors.

Main Methods:

  • In vitro studies using human glioma cell lines.
  • In vivo studies involving subcutaneous and intracerebral human glioma xenografts in mice.
  • Ex vivo testing on primary glioma cell cultures derived from patient specimens.

Main Results:

  • Reovirus demonstrated potent oncolytic activity, killing 83% of tested malignant glioma cell lines.
  • Significant tumor regression and prolonged survival were observed in mouse models.
  • Reovirus effectively killed 100% of tested primary glioma specimens but not meningiomas.

Conclusions:

  • Reovirus exhibits potent anti-glioma activity across in vitro, in vivo, and ex vivo models.
  • Oncolysis using reovirus presents a promising therapeutic strategy for malignant gliomas.
  • Reovirus holds potential as a treatment for various human cancers.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...